Predictive Oncology Inc. (AGPU)
NASDAQ · Technology
Predictive Oncology Inc. EBITDA 2017–2025
Predictive Oncology Inc. annual/quarterly ebitda history and growth rate from 2018 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Predictive Oncology Inc. ebitda for the quarter ending March 31, 2026 was -7.7 M, a 241.56% increase year-over-year.
- Predictive Oncology Inc. ebitda for the twelve months ending March 31, 2026 was -14.4 M, a 8.49% increase year-over-year.
- Predictive Oncology Inc. annual ebitda for 2025 was -180.8 M, a 1677.37% increase from 2024.
- Predictive Oncology Inc. annual ebitda for 2024 was -10.2 M, a 14.33% decrease from 2023.
- Predictive Oncology Inc. annual ebitda for 2023 was -11.9 M, a 51.97% decrease from 2022.
- Predictive Oncology Inc. annual ebitda for 2022 was -24.7 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Predictive Oncology Inc. EBITDA — FAQ
Predictive Oncology Inc. (AGPU) ebitda over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AGPU's ebitda history?
The chart and table above show Predictive Oncology Inc.'s ebitda by year and by quarter, including the growth rate.